Home > Annual Financials > HESTER BIOSCIENCES

HESTER BIOSCIENCES Financial Statement Analysis
[BOM: 524669|NSE : HESTERBIO]

The Revenues of HESTER BIOSCIENCES have increased by 2.15% YoY .
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has increased by 102.41 % YoY.
COMMUNITY POLL
for HESTER BIOSCIENCES
Please provide your vote to see the results

HESTER BIOSCIENCES Last 5 Annual Financial Results
[BOM: 524669|NSE : HESTERBIO]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹311 Cr₹305 Cr₹266 Cr₹235 Cr₹214 Cr
Expenses ₹250 Cr₹251 Cr₹216 Cr₹175 Cr₹146 Cr
Operating Profit (Excl OI) ₹61 Cr₹53 Cr₹50 Cr₹60 Cr₹69 Cr
Other Income ₹3.92 Cr₹11 Cr₹15 Cr₹14 Cr₹4.68 Cr
Interest ₹13 Cr₹20 Cr₹9.32 Cr₹4.06 Cr₹6.60 Cr
Depreciation ₹17 Cr₹17 Cr₹21 Cr₹17 Cr₹13 Cr
Profit Before Tax ₹40 Cr₹32 Cr₹40 Cr₹54 Cr₹50 Cr
Profit After Tax ₹29 Cr₹21 Cr₹28 Cr₹39 Cr₹35 Cr
Consolidated Net Profit ₹27 Cr₹19 Cr₹27 Cr₹39 Cr₹34 Cr
Earnings Per Share (Rs)₹65.40₹32.31₹22.20₹31.30₹46.22
PAT Margin (%)17.279.266.9410.4616.67
ROE(%)17.059.517.4110.3916.17
ROCE(%)16.219.939.599.6014.12
Total Debt/Equity(x)0.520.660.820.960.86

Key Financials

Market Cap : ₹ 1,877.5 Cr
Revenue (TTM) : ₹ 332.6 Cr
Net Profit(TTM) : ₹ 51.1 Cr
EPS (TTM) : ₹ 60.1
P/E (TTM) : 36.7

Industry Peers & Returns1W1M1Y
HESTER BIOSCIENCES -0% 13% 19.9%
SUN PHARMACEUTICAL INDUSTRIES 1.7% 6.4% 12.1%
DIVIS LABORATORIES 3% 2.8% 0.9%
TORRENT PHARMACEUTICALS 2.3% 9.1% 44.6%
CIPLA 0.3% 6.1% -3.7%
DR REDDYS LABORATORIES -0.1% 8.9% 1.9%
MANKIND PHARMA 1.8% 6.7% 8%
LUPIN 2.9% 9.5% 24.5%
ZYDUS LIFESCIENCES 1.7% 6% 12%


HESTER BIOSCIENCES Revenues
[BOM: 524669|NSE : HESTERBIO]

Y-o-Y

2.15 %

5 Yr CAGR

9.76 %

Years Revenues % Change
Mar2026 ₹311 Cr
2.15
Mar2025 ₹305 Cr
14.45
Mar2024 ₹266 Cr
13.23
Mar2023 ₹235 Cr
9.65
Mar2022 ₹214 Cr -


HESTER BIOSCIENCES Operating Profit
[BOM: 524669|NSE : HESTERBIO]

Y-o-Y

14.83 %

5 Yr CAGR

-2.89 %

Years Operating Profit % Change
Mar2026 ₹61 Cr
14.83
Mar2025 ₹53 Cr
5.48
Mar2024 ₹50 Cr
-15.97
Mar2023 ₹60 Cr
-12.64
Mar2022 ₹69 Cr -

Operating Margins
Y-o-Y

12.37 %

5 Yr CAGR

-11.53 %

Years Operating Margin% % Change
Mar2026 19.62%
12.37
Mar2025 17.46%
-7.81
Mar2024 18.94%
-25.78
Mar2023 25.52%
-20.32
Mar2022 32.03% -

HESTER BIOSCIENCES Profit After Tax
[BOM: 524669|NSE : HESTERBIO]

Y-o-Y

45.52 %

5 Yr CAGR

-5.47 %

Years Profit After Tax % Change
Mar2026 ₹27 Cr
45.52
Mar2025 ₹19 Cr
-29.06
Mar2024 ₹27 Cr
-32.28
Mar2023 ₹39 Cr
14.20
Mar2022 ₹34 Cr -

PAT Margins
Y-o-Y

86.50 %

5 Yr CAGR

0.89 %

Years PAT Margin(%) % Change
Mar2026 17.27 %
86.50
Mar2025 9.26 %
33.43
Mar2024 6.94 %
-33.65
Mar2023 10.46 %
-37.25
Mar2022 16.67 % -

HESTER BIOSCIENCES Earnings Per Share (EPS)
[BOM: 524669|NSE : HESTERBIO]

Y-o-Y

102.41 %

5 Yr CAGR

9.07 %

Years EPS % Change
Mar2026 ₹65
102.41
Mar2025 ₹32
45.54
Mar2024 ₹22
-29.07
Mar2023 ₹31
-32.28
Mar2022 ₹46 -

HESTER BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 524669|NSE : HESTERBIO]

Y-o-Y

63.24 %

5 Yr CAGR

3.51 %

Years ROCE % Change
Mar2026 16.21%
63.24
Mar2025 9.93%
3.55
Mar2024 9.59%
-0.10
Mar2023 9.6%
-32.01
Mar2022 14.12% -

HESTER BIOSCIENCES Share Price vs Sensex

Current Share Price : ₹2,208.9
Current MarketCap: ₹ 1,877.5 Cr
Updated EOD on :Jul 03,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

-0%

13%

19.9%

SENSEX

0.9%

4.2%

-6%

HESTER BIOSCIENCES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 3.1% 8.2% 14.9%
No NSE index found

You may also like the below Video Courses


FAQ about HESTER BIOSCIENCES Financials


How the annual revenues of HESTER BIOSCIENCES have changed ?

The Revenues of HESTER BIOSCIENCES have increased by 2.15% YoY .

How the Earnings per Share (EPS) of HESTER BIOSCIENCES have changed?

The Earnings Per Share (EPS) of HESTER BIOSCIENCES has increased by 102.41 % YoY .